Controlled release hydrocodone formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8142811
APP PUB NO 20090202629A1
SERIAL NO

12378586

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PURDUE PHARMA L.P.STAMFORD, CT396

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Hua-Pin Englewood Cliffs, US 54 2210
Masselink, John K Old Tappan, US 24 682
Oshlack, Benjamin New York, US 217 11252
Tonelli, Alfred P Congers, US 15 777

Cited Art Landscape

Patent Info (Count) # Cites Year
 
RIJKSUNIVERSITEIT GRONINGEN (1)
4708874 Devices for the controlled release of active substances, as well as process for the preparation thereof 78 1986
 
PHARMACIA & UPJOHN AB (1)
5614218 Controlled release preparation 63 1994
 
ELAN CORPORATION, PLC (2)
4609542 New pharmaceutical forms for administration of medicaments by oral route, with programmed release 51 1985
5637320 Controlled absorption naproxen formulation for once-daily administration 66 1994
 
NIRO HOLDING A/S (1)
5030400 Process and an apparatus for agglomeration of a powdery material 83 1990
 
VIRGINIA COMMONWEALTH UNIVERSITY (2)
5321012 Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance 186 1993
5502058 Method for the treatment of pain 164 1994
 
PFIZER INC. (1)
4861596 Rolled matrix device having enhanced ability to unroll and method for its production 29 1988
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5026560 Spherical granules having core and their production 170 1988
 
NIPPON SHINYAKU CO., LTD. (1)
5456923 Method of manufacturing solid dispersion 164 1993
 
HOECHST AKTIENGESELLSCHAFT (1)
4935246 Process for the coating of granules 126 1988
 
CIBA-GEIGY CORPORATION (1)
4548990 Crosslinked, porous polymers for controlled drug delivery 139 1983
 
GRUENENTHAL GMBH (1)
5601842 Sustained release drug formulation containing a tramadol salt 80 1996
 
Merck Sharp & Dohme I.A. Corp. (1)
4377568 Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same 80 1981
 
RHODIA INC. (2)
6264983 Directly compressible, ultra fine acetaminophen compositions and process for producing same 32 1999
6607750 Directly compressible acetaminophen compositions 35 2001
 
WARNER-LAMBERT COMPANY (4)
4483847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 89 1983
4600645 Process for treating dosage forms 78 1985
5068110 Stabilization of enteric coated dosage form 79 1989
5167964 Semi-enteric drug delivery systems and methods for preparing same 94 1992
 
FOREST LABORATORIES, INC. (1)
4389393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 316 1982
 
FISONS CORPORATION (1)
4959219 Coating barriers comprising ethyl cellulose 51 1988
 
ROHM GMBH (1)
4520172 Method for coating medicaments 62 1983
 
AMERICAN CYANAMID COMPANY (1)
5283065 Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 113 1992
 
MERIAL (1)
5958425 Viral vaccines 3 1997
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5169645 Directly compressible granules having improved flow properties 157 1989
 
ZYMA SA (1)
4728513 Granular delayed-release form of pharmaceutically active substances 85 1986
 
Duphar International Research B.V. (1)
5219575 Compositions with controlled zero-order delivery rate and method of preparing these compositions 41 1990
 
DEUTSCHE BANK AG NEW YORK BRANCH (1)
4983730 Water soluble cellulose acetate composition having improved processability and tensile properties 81 1988
 
RICHARDSON-VICKS INC. (1)
4996047 Sustained release drug-resin complexes 116 1988
 
ALZA CORPORATION (7)
5019397 Aqueous emulsion for pharmaceutical dosage form 112 1988
5024842 Annealed coats 104 1990
5460826 Morphine therapy 138 1994
6491945 Hydrocodone therapy 59 1994
5593695 Morphine therapy 81 1995
* 5866161 Hydrocodone therapy 75 1996
5667805 Morphine therapy 71 1996
 
VALEANT INTERNATIONAL BERMUDA (1)
5518730 Biodegradable controlled release flash flow melt-spun delivery system 232 1992
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4421736 Sustained release diethylpropion compositions 79 1982
 
EURO-CELTIQUE S.A. (12)
4443428 Extended action controlled release compositions 145 1982
4844907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 154 1986
5071646 Pharmaceutical ion exchange resin composition 150 1989
5356467 Controlled release coatings derived from aqueous dispersions of zein 227 1993
5500227 Immediate release tablet cores of insoluble drugs having sustained-release coating 204 1993
5670172 Pharmaceutical spheroid formulation 102 1995
5849240 Method of preparing sustained release pharmaceutical compositions 182 1996
5891471 Pharmaceutical multiparticulates 160 1996
5843480 Controlled release diamorphine formulation 129 1996
5879705 Sustained release compositions of morphine and a method of preparing pharmaceutical compositions 169 1997
5965163 Substained release compositions and a method of preparing pharmaceutical compositions 171 1997
6572885 Orally administrable opioid formulations having extended duration of effect 110 2001
 
PURDUE PHARMA L.P. (25)
4828836 Controlled release pharmaceutical composition 222 1987
4834985 Controlled release pharmaceutical composition 234 1987
4990341 Controlled release hydromorphone composition 188 1989
5266331 Controlled release oxycodone compositions 260 1991
5273760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 269 1991
5286493 Stabilized controlled release formulations having acrylic polymer coating 265 1992
5549912 Controlled release oxycodone compositions 253 1993
5472712 Controlled-release formulations coated with aqueous dispersions of ethylcellulose 254 1993
5580578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 238 1993
5478577 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level 267 1993
5411745 Powder-layered morphine sulfate formulations 163 1994
5965161 Extruded multi-particulates 201 1994
5639476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 540 1995
5508042 Controlled release oxycodone compositions 276 1995
5968551 Orally administrable opioid formulations having extended duration of effect 269 1995
5958459 Opioid formulations having extended controlled released 177 1995
5656295 Controlled release oxycodone compositions 238 1996
5681585 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 151 1996
5672360 Method of treating pain by administering 24 hour oral opioid formulations 248 1996
6143322 Method of treating humans with opioid formulations having extended controlled release 182 1997
5958452 Extruded orally administrable opioid formulations 237 1997
6103261 Opioid formulations having extended controlled release 172 1999
6294195 Orally administrable opioid formulations having extended duration of effect 161 1999
6733783 Controlled release hydrocodone formulations 171 2001
2004/0266,807 Controlled release hydrocodone formulations 71 2004
 
ASAHI KASEI CHEMICALS CORPORATION (1)
5384130 Spherical seed cores, spherical granules and process for production thereof 63 1993
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4844909 Controlled release hydromorphone composition 179 1987
 
ALPHARMA PHARMACEUTICALS, LLC (3)
5202128 Sustained release pharmaceutical composition 192 1990
5330766 Sustained release pharmaceutical composition 159 1993
5378474 Sustained release pharmaceutical composition 166 1993
 
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (1)
4464378 Method of administering narcotic antagonists and analgesics and novel dosage forms containing same 215 1981
 
ARCHIMEDES DEVELOPMENT LIMITED (1)
5629011 Composition for nasal administration 94 1994
 
MILES INC. (1)
4797410 Suppression of withdrawal symptoms in opioid-induced tolerance or dependence 51 1987
 
DRUGTECH CORPORATION (2)
5122384 Oral once-per-day organic nitrate formulation which does not induce tolerance 54 1989
5133974 Extended release pharmaceutical formulations 313 1990
 
FMC CORPORATION (3)
5206030 Film-forming composition and use for coating pharmaceuticals, foods and the like 65 1990
5248516 Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like 53 1991
5258436 Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like 43 1991
 
DepoMed Systems, Inc. (1)
5007790 Sustained-release oral drug dosage form 186 1989
 
UCB PHARMA S.A. (1)
6699502 Pharmaceutical compositions for controlled release of active substances 59 1999
 
GLATT GMBH (1)
5132142 Apparatus and method for producing pellets by layering power onto particles 72 1991
 
GACELL LABORATORIES AB (3)
4557925 Membrane-coated sustained-release tablets and method 122 1984
5178868 Dosage form 74 1991
5520931 Controlled release morphine preparation 65 1995
 
CADBURY ADAMS USA LLC (1)
4894234 Novel drug delivery system for antiarrhythmics 92 1988
 
PURDUE PHARMA COMPANY, THE (2)
4861598 Controlled release bases for pharmaceuticals 237 1986
4970075 Controlled release bases for pharmaceuticals 203 1989
 
WATSON LABORATORIES, INC. (1)
4806337 Erodible matrix for sustained release bioactive composition 151 1986
 
SPRING AG METALLWARENFABRIKEN AG (1)
5292461 Process for the production of pellets 76 1991
 
F.H. FAULDING & CO. LIMITED (1)
5196203 Theophylline dosage form 61 1991
 
PUREUE PHARMA L.P. (1)
4834984 Controlled release dihydrocodeine composition 171 1987
 
Shionogi & Co., Ltd. (1)
5023089 Sustained-release preparations and the process thereof 68 1989
 
TCF NATIONAL BANK (1)
5126145 Controlled release tablet containing water soluble medicament 129 1990
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
OPKO RENAL, LLC (2)
9408858 Method for treating secondary hyperparathyroidism in CKD 0 2015
9498486 Method for controlled release oral dosage of a vitamin D compound 0 2016
 
PURDUE PHARMA L.P. (20)
8980291 Controlled release hydrocodone formulations 3 2010
* 8551520 Controlled release hydrocodone 28 2012
8975271 Controlled release hydrocodone formulations 0 2013
* 9060940 Controlled release hydrocodone 7 2014
8975273 Controlled release hydrocodone formulations 1 2014
8951555 Controlled release hydrocodone formulations 10 2014
9023401 Controlled release hydrocodone formulations 11 2014
9056052 Controlled release hydrocodone formulations 10 2015
9056107 Controlled release hydrocodone formulations 0 2015
9320717 Controlled release hydrocodone formulations 0 2015
9278074 Controlled release hydrocodone formulations 0 2015
9289391 Controlled release hydrocodone formulations 5 2015
9205055 Controlled release hydrocodone formulations 5 2015
9205056 Controlled release hydrocodone formulations 5 2015
9198863 Controlled release hydrocodone formulations 5 2015
9572804 Controlled release hydrocodone formulations 0 2016
9572805 Controlled release hydrocodone formulations 0 2016
9526724 Controlled release hydrocodone formulations 0 2016
9517236 Controlled release hydrocodone formulations 0 2016
9504681 Controlled release hydrocodone formulations 0 2016
 
EGALET LTD. (7)
8877241 Morphine controlled release system 2 2004
9005660 Immediate release composition resistant to abuse by intake of alcohol 2 2010
9023394 Formulations and methods for the controlled release of active drug substances 1 2013
8808745 Morphine polymer release system 6 2013
9044402 Abuse-deterrent pharmaceutical compositions for controlled release 1 2014
9375428 Morphine controlled release system 0 2014
9358295 Immediate release composition resistant to abuse by intake of alcohol 1 2015
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 27, 2019
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 27, 2023
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00